Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-08
2008-01-08
Owens, Amelia A. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S468000
Reexamination Certificate
active
07317115
ABSTRACT:
The object of the present invention is a novel mandelate salt of a substituted tetracyclic tetrahydrofuran derivative according to Formula (I)the N-oxide forms and the stereochemically isomeric forms thereof, wherein R1and R2each independently are hydrogen or C1-6alkyl and R3and R4each independently are hydrogen or halogen. In the foregoing definitions C1-6alkyl defines straight and branched saturated hydrocarbon radicals having from 1 to 6 carbon atoms such as, for example, methyl, ethyl, propyl, butyl, 1-methylpropyl, 1,1-dimethylethyl, pentyl or hexyl. The novel mandelate salt is not light-sensitive and is far more stable than the prior art salts at room temperature, enhanced temperature and at relative high humidities and in aqueous media. Also disclosed are pharmaceutical compositions comprising mandelate salts according to the invention, mandelate salts according to the invention for use as a medicine, a process for preparing the mandelate salts according to the invention and the use of the mandelate salts and pharmaceutical compositions comprising mandelate salts according to the invention for the treatment or the prevention of CNS disorders, cardiovascular disorders and gastrointestinal disorders.
REFERENCES:
patent: 5658899 (1997-08-01), Hansen et al.
patent: 6667317 (2003-12-01), Chenard et al.
patent: 3644462 (1986-12-01), None
patent: WO 97/38991 (1997-10-01), None
patent: WO 97/44014 (1997-11-01), None
patent: WO 99/19317 (1999-04-01), None
International Search Report dated Mar. 14, 2003 for PCT/EP02/11136.
Hoyer, Daniel et al., VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin), Pharmacological Reviews, The American Society for Pharmacology and Experimental Therapeutics, 1994, vol. 46, No. 2, pp. 157-203.
Meert, Theo F., et al., “Partial and Complete Blockade of 5-Hydroxytryptophan (5-HTP)-induced Head Twitches in the Rat: A Study of Ritanserin (R 55 667), Risperidone (R 64 766), and Related Compounds,” Drug Development Research, 13: 237-244 (1988).
Niemegeers, C.J.E. et al., “Interaction of Drugs with Apomorphine, Tryptamine and Norepinephrine. A New In vivo Approach: the ATN-Test in Rats,” Arch. Int. Pharmacodyn., 227, 238-253 (1977).
Monkovic, I. et al., “Substituted Tetrahydrofurfurylamines as Potential Antidepressants,” Journale of Medicinal Chemistry (1973), vol. 16, No. 4, pp. 403-407.
Medaer Bart Petrus Anna Maria Jozef
Ruysschaert Yves Georges
Stokbroekx Sigrid Carl Maria
Weerts Johan Erwin Edmond
Willems Joannes Josephus Maria
Janssen Pharmaceutica N.V.
Owens Amelia A.
Woodcock & Washburn LLP
LandOfFree
Mandelates salts of substituted tetracyclic tetrahydrofuran... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mandelates salts of substituted tetracyclic tetrahydrofuran..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mandelates salts of substituted tetracyclic tetrahydrofuran... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2808451